{"id":53312,"date":"2023-01-25T23:02:25","date_gmt":"2023-01-25T22:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/"},"modified":"2023-01-25T23:02:25","modified_gmt":"2023-01-25T22:02:25","slug":"iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/","title":{"rendered":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023"},"content":{"rendered":"
\n

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (\u201cIQVIA\u201d) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http:\/\/ir.iqvia.com<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nTo listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http:\/\/ir.iqvia.com<\/a>. To participate in the conference call, interested parties must register in advance by clicking on this link<\/a><\/b>. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants can connect to the call using the information provided in the confirmation email and will be placed directly into the call.\n<\/p>\n

\nA replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit http:\/\/ir.iqvia.com<\/a>.\n<\/p>\n

\nAbout IQVIA<\/b>\n<\/p>\n

\nIQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence\u2122 delivers powerful insights with speed and agility \u2014 enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.\n<\/p>\n

\nIQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA\u2019s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com<\/a>.\n<\/p>\n

\nIQVIAFIN<\/b>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com<\/a>)
\n
+1.973.316.3828\n<\/p>\n

\nTrent Brown, IQVIA Media Relations (trent.brown@iqvia.com<\/a>)
\n
+1.919.780.3221\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (\u201cIQVIA\u201d) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53312","6":"format-standard","7":"category-industry"},"yoast_head":"\nIQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (\u201cIQVIA\u201d) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-25T22:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023\",\"datePublished\":\"2023-01-25T22:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/\"},\"wordCount\":413,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005606\\\/en\\\/1695851\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/\",\"name\":\"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005606\\\/en\\\/1695851\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"datePublished\":\"2023-01-25T22:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005606\\\/en\\\/1695851\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230125005606\\\/en\\\/1695851\\\/21\\\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/","og_locale":"en_US","og_type":"article","og_title":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend","og_description":"RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (\u201cIQVIA\u201d) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-25T22:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023","datePublished":"2023-01-25T22:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/"},"wordCount":413,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/","url":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/","name":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","datePublished":"2023-01-25T22:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230125005606\/en\/1695851\/21\/Website_Featured_JPG-IQVIA_Logo_-_Tricolor.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iqvia-to-announce-fourth-quarter-and-full-year-2022-results-on-february-10-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53312","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53312"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53312\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}